导航
| 统计阶段 | 收益率 | 同类排名 |
|---|---|---|
| 今年以来 | 41.35% | 99/1050 |
| 近一周 | 2.24% | 92/1104 |
| 近一月 | -2.17% | 389/1103 |
| 近一季 | -4.47% | 446/1092 |
| 近半年 | 30.22% | 85/1070 |
| 近一年 | 41.50% | 111/1018 |
| 近两年 | 125.61% | 143/926 |
| 近三年 | 91.22% | 112/834 |
| 成立以来 | 99.05% | - |
| 年份 | 年收益 | 1季度 | 2季度 | 3季度 | 4季度 |
| 2026 | - - |
-0.11% 493/1070 |
80.65% 103/1101 |
- - |
- - |
| 2025 | 30.62% 463/1065 |
4.10% 469/1014 |
-0.45% 725/1038 |
34.17% 292/1050 |
-6.05% 741/1065 |
| 2024 | 3.49% 484/1011 |
-8.40% 715/960 |
1.72% 206/983 |
11.02% 544/991 |
0.06% 313/1011 |
| 2023 | -14.90% 518/952 |
-1.84% 703/880 |
-4.83% 511/895 |
-8.61% 533/915 |
-0.32% 135/952 |
| 2022 | -22.90% 434/867 |
-23.19% 676/773 |
9.65% 283/806 |
-2.21% 33/845 |
-6.40% 680/867 |
| 2021 | 5.52% 295/740 |
-11.48% 516/580 |
11.61% 316/659 |
-2.00% 254/704 |
8.99% 100/740 |
| 2020 | 77.05% 105/554 |
7.26% 54/419 |
41.02% 20/466 |
3.30% 383/517 |
13.31% 243/554 |
| 2019 | - - |
- - |
-4.97% 710/1228 |
4.68% 208/390 |
12.39% 104/410 |
| 2018 | - - |
- - |
- - |
- - |
- - |
| 2017 | - - |
- - |
- - |
- - |
- - |
| 2016 | - - |
- - |
- - |
- - |
- - |
| 2015 | - - |
- - |
- - |
- - |
- - |
| 2014 | - - |
- - |
- - |
- - |
- - |
| 2013 | - - |
- - |
- - |
- - |
- - |
| 2012 | - - |
- - |
- - |
- - |
- - |
| 基金名称 | 最新净值 | 季增长率 |
| 招商前沿医疗保健股票A | 0.8511 | 59.95% |
| 招商前沿医疗保健股票C | 0.8165 | 53.69% |
| 招商医药健康产业股票 | 2.6450 | 48.73% |
| 前海开源公共卫生股票A | 0.4748 | 42.37% |
| 广发医药精选股票A | 1.3315 | 41.03% |
| 嘉实医疗保健股票 | 2.6190 | 39.05% |
| 广发医药精选股票C | 1.3103 | 38.32% |
| 前海开源公共卫生股票C | 0.4647 | 37.30% |
| 交银医药创新股票A | 2.9144 | 36.05% |
| 交银医药创新股票C | 3.0948 | 35.86% |
| 华夏科技成长股票 VS. 东吴新产业精选股票A(580008) |